Condition
Pharmacologic Actions
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
P 1 (2)
P 4 (2)
Trial Status
Completed3
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02046512Phase 4Completed
Probiotics to Promote Intestinal Health
NCT03526575Phase 4Completed
Optimize Astronaut Sleep Medication Efficacy and Individual Effects
NCT01988311Phase 1Completed
Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
NCT01121510Phase 1Withdrawn
Hemostatic Closure of Femoral Artery Access Site, Using the QuickClose Design 9 System
Showing all 4 trials